Skip to content

Hyrax Vs. Invisalign Palatal Expander Clinical Study

Hyrax Vs. Invisalign Palatal Expander Clinical Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06662279
Enrollment
36
Registered
2024-10-28
Start date
2024-10-25
Completion date
2026-01-31
Last updated
2024-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crowding, Malocclusions, Narrow Maxilla, Narrow Maxillary Arch

Brief summary

The purpose of this study is to compare expansion result and the overall experience between the Invisalign Palatal Expander and the Hyrax expander.

Interventions

DEVICERemovable Rapid Palatal Expander

Removable palatal expander where expanders are changed to obtain up to .25mm expansion per expander

DEVICEBanded Palatal Expander

Palatal expander cemented into mouth where a screw is turned to obtain .25mm expansion per turn

Sponsors

Align Technology, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 11 Years
Healthy volunteers
No

Inclusion criteria

* Subject ages 6-11 years old * Subject must need maxillary expansion * Subjects must have erupted dentition in the area of the primary molars or permanent premolars and the first permanent molar

Exclusion criteria

* Subjects with palatal exostosis/surface aberration/ cleft palate * Subject's dentition not compatible with device or allergy to device materials * Subject with active caries, periodontal disease, TMD

Design outcomes

Primary

MeasureTime frameDescription
width of palate after expansionfrom enrollment to study completion, approximately 4 monthsintraoral scans will be taken of the subject's upper arch, including palate throughout the study and widths will be measured

Countries

United States

Contacts

Primary ContactSmita Sharma
skaushik@aligntech.com408-470-4079
Backup ContactSherri Wilson-Lopes
swilson@aligntech.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026